Headquartered in Winston-Salem, ProKidney leases an undetermined amount of space at the general-industrial-zoned building at ...

Biotech company ProKidney will no longer be coming to Greensboro, according to the City of Greensboro Chamber of Commerce.

It is unclear what will happen to ProKidney's plans for a $458-million, 330-job commercial manufacturing facility in ...

The 73 Business Center on Greenbourne Drive in Greensboro is pictured. ProKidney Corp., a Winston-Salem company focused on ...

ProKidney, which works to treat chronic kidney disease, had previously announced plans to expand its operation into ...

ProKidney's REACT® therapy shows kidney function stabilization. Find out why PROK stock is risky due to cash issues and ...

Judah Frommer, an analyst from Morgan Stanley, maintained the Hold rating on ProKidney (PROK – Research Report). The associated price target remains the same with $3.00. Judah Frommer has given his ...

“Notably, the FDA also confirmed that ProKidney could consider using eGFR slope as a surrogate endpoint on an accelerated approval pathway for rilparencel. We look forward to continuing our dialogue ...

“Notably, the FDA also confirmed that ProKidney could consider using eGFR slope as a surrogate endpoint on an accelerated approval pathway for rilparencel. We look forward to continuing our ...

FDA confirmed in a recent FDA Type B meeting under RMAT designation that the PROACT 1 Phase 3 study could be sufficient to support a full U.S. regulatory approval of rilparencelFDA also confirmed ...

The live webcasts will also be accessible through the “Events” section of the Investor Relations tab within ProKidney’s website at www.prokidney.com. Following the completion of each event ...